This inventor holds 1 USPTO granted patent. Top assignee: Universitè De Genève. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Cinzia Stella: Innovator in Monoclonal Antibody Formulations
Introduction
Cinzia Stella is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of biomedical research, particularly in the development of innovative formulations for monoclonal antibodies. Her work focuses on enhancing the efficacy and stability of these therapeutic agents.
Latest Patents
Cinzia holds a patent for "Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs." This invention is directed towards combination formulations of monoclonal antibodies with anti-inflammatory agents, along with related methods and uses. The patent highlights her commitment to improving treatment options for patients.
Career Highlights
Cinzia is affiliated with the University of Geneva, where she conducts her research and development activities. Her academic background and expertise have positioned her as a leader in her field. She has dedicated her career to advancing medical science through innovative solutions.
Collaborations
Cinzia has collaborated with notable colleagues, including Robert Gurny and Cyrus Tabatabay. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Cinzia Stella's contributions to the field of monoclonal antibody formulations exemplify her dedication to innovation in biomedical research. Her work continues to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile